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OPPORTUNITIES FOR APPLYING BIOMEDICAL PRODUCTION  
AND MANUFACTURING METHODS TO THE DEVELOPMENT  
OF THE CLEAN MEAT INDUSTRY 
Christie Lagally and Liz Specht, Ph.D.  |  Senior Scientists  |  The Good Food Institute  |  Washington, D.C. 
What is clean meat? 
Clean meat (meat grown using cell culture and tissue engineering 
methods, rather than obtained from animal slaughter) is an emergent 
biotechnology industry that will ameliorate the serious environmental, 
sustainability, global public health, and animal welfare concerns of 
conventional animal agriculture.  
Animal agriculture poses massive threats to human health, the 
environment, and animal welfare. It is a leading cause of environmental 
destruction – including deforestation, ocean dead zones, and water and 
air pollution – and it contributes more greenhouse gas emissions than 
the entire global transportation sector. Furthermore, rearing animals 
poses significant public health threats from antibiotic resistance and 
zoonotic disease epidemics. Finally, consumers are increasingly 
concerned about the treatment of farmed animals, as evidenced by a 
growing number of legal reforms and governmental mandates to 
improve conditions and decrease the prevalence of animal protein in 
our diets. 
Producing meat via large-scale cell culture alleviates all of these 
burdens by removing animal rearing and slaughter from the process. 
Opportunities for involvement 
Get involved 
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Critical technologies 
Cell Lines 
•  Derived from agriculturally-relevant species 
•  Capable of differentiation into meat-relevant 
cell types (muscle, fat, fibroblast, 
endothelial, etc.) 
•  Genetically stable and immortalized 
•  Optimized for large-scale growth (tolerate 
suspension, controlled differentiation, etc.) 
Cell culture media 
•  Xeno-free, antibiotic-free 
•  Chemically defined 
•  Optimized for clean meat-relevant cell lines 
•  Extremely low cost and high-scale 
production capacity 
•  Synthetic growth factors for fine-tuning 
cellular responses and differentiation 
Scaffolds 
•  Edible and/or biodegradable and food 
grade materials 
•  Support cell adherence 
•  Support vascularization and media 
perfusion 
•  Biomechanical properties suitable for tissue 
maturation 
•  Scalable production capacity 
Bioreactors 
•  Support cell line proliferation 
•  Support tissue maturation / perfusion  
(may require mechanical stimulus) 
•  Large volume 
•  Facilitate high-yield cell harvesting 
•  Real-time cell monitoring platform for QC 
•  Integrated media filtration and recycling 
Meat design requirements 
Figure 1: The first clean meatball, showcased in January 2016 in San 
Francisco. Photo courtesy of Memphis Meats. 
Figure 4: The first 
clean meat 
hamburger, 
unveiled in 
London in 2013.  
 
Photo courtesy of 
Prof. Mark Post. 
 
Learn more at:  
https://
culturedbeef.mumc.
maastricht 
university.nl 
Critical Technology Elements (CTEs) for clean meat include 
immortalized cell lines for meat-relevant animal species (e.g. chicken, 
pig, fish, etc.), xeno-free media optimized for proliferation and 
differentiation of these cell lines, edible or biodegradable scaffolding to 
support vascularized tissue, and efficient bioreactors for cell 
proliferation and tissue maturation.  
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Roughly 93 billion pounds of meat are produced annually in North 
America. Hence, cell and tissue manufacturers and suppliers have 
massive growth opportunities in clean meat production.  
Revenue generation may occur prior to developing clean meat as a 
final product – for example, cultured muscle and/or fat cells may serve 
as valuable ingredients to improve the taste profile or functionality of 
plant-based products. Furthermore, technologies developed with clean 
meat applications in mind will exhibit substantial cross-licensing 
opportunities within cellular therapeutics and regenerative medicine.  
The Good Food Institute has produced a Technology Readiness 
Assessment (TRA) for Clean Meat to establish the design 
requirement relationships among the CTEs. This assessment has 
elucidated abundant opportunities to expand existing product lines 
tailored towards clean meat applications. For example: 
•  Bioreactor systems for whole-cell harvesting can be applied to cell 
proliferation for clean meat.  
•  Scaffolds for wound healing can be immediately used for tissue 
engineering of meat at small scales. 
•  Cell culture media suppliers can develop bulk, low-cost formulations 
and offer optimization services with clean meat applications in mind. 
Developing new food technologies that facilitate a global shift away 
from animal products and towards more sustainable, healthy, and 
humane alternatives is arguably one of the single most impactful areas 
for commercialization because of the massive and far-reaching impacts 
of animal agriculture. 
GFI is a donor-supported, non-profit organization that uses technology 
and markets to solve the world’s most pressing problems.  
Figure 3: Schematic of a possible two-stage production process for 
large-scale clean meat production. The Good Food Institute, 2016. 
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Clean meat production begins with a cell line starter to initiate 
proliferation in a suspension bioreactor. Media in this bioreactor is a 
commodity item, and should be utilized efficiently via the media 
recycling system. The differentiation and tissue maturation stage 
occurs in a second reactor with a scaffold for tissue formation. The final 
product comprises complex tissues composed of multiple cell types.   
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Figure 2: Conceptual clean meat industry mind map illustrating CTEs 
and supporting areas of opportunity within this emerging sector. 
